1999
DOI: 10.1016/s0190-9622(99)70359-2
|View full text |Cite
|
Sign up to set email alerts
|

Acitretin in psoriasis: An overview of adverse effects

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
155
8
13

Year Published

2003
2003
2024
2024

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 184 publications
(183 citation statements)
references
References 22 publications
3
155
8
13
Order By: Relevance
“…[86][87][88] Potential teratogenic effects associated with retinoids are characteristic of those associated with hypervitaminosis A. 89,90 Retinoid embryopathy can result in craniofacial dysmorphias such as high palate and anophthalmia, abnormalities of appendages including syndactyly and absence of terminal phalanges, malformations of the hip, meningoencephalocele, and multiple synostosis. [89][90][91][92] The teratogenic risk is particularly high for women exposed to treatment during the first trimester of pregnancy.…”
Section: Teratogenicitymentioning
confidence: 99%
See 4 more Smart Citations
“…[86][87][88] Potential teratogenic effects associated with retinoids are characteristic of those associated with hypervitaminosis A. 89,90 Retinoid embryopathy can result in craniofacial dysmorphias such as high palate and anophthalmia, abnormalities of appendages including syndactyly and absence of terminal phalanges, malformations of the hip, meningoencephalocele, and multiple synostosis. [89][90][91][92] The teratogenic risk is particularly high for women exposed to treatment during the first trimester of pregnancy.…”
Section: Teratogenicitymentioning
confidence: 99%
“…89,90 Retinoid embryopathy can result in craniofacial dysmorphias such as high palate and anophthalmia, abnormalities of appendages including syndactyly and absence of terminal phalanges, malformations of the hip, meningoencephalocele, and multiple synostosis. [89][90][91][92] The teratogenic risk is particularly high for women exposed to treatment during the first trimester of pregnancy. Available data do not appear to indicate any reproductive safety risks due to paternal treatment with acitretin.…”
Section: Teratogenicitymentioning
confidence: 99%
See 3 more Smart Citations